A New Frontier in Cardiology: Experimental Oral Drug Enlicitide Shows Promise in Sashing Cholesterol Levels on September 20, 2026 Posted by
Landmark Advancement in Sleep Apnea Care: Portland Surgical Center Pioneers Bilateral Hypoglossal Nerve Stimulation on September 20, 2026 Posted by
The Silent Epidemic: Unpacking the Multidimensional Impact of Chronic Stress on Global Health on September 20, 2026 Posted by
The End of an Era: House Passes "Common Cents Act" to Permanently Retire the Penny on September 20, 2026 Posted by
The Digital Guard: Why Imprivata is Treating AI Agents Like Unvetted Contract Nurses on September 20, 2026 Posted by
The Sweet Illusion: Reassessing the Global Role of Non-Sugar Sweeteners in Public Health on September 20, 2026 Posted by
A New Frontier in Cardiology: Experimental Oral Drug Enlicitide Shows Promise in Sashing Cholesterol Levels on September 20, 2026 Posted by
Landmark Advancement in Sleep Apnea Care: Portland Surgical Center Pioneers Bilateral Hypoglossal Nerve Stimulation on September 20, 2026 Posted by
The Silent Epidemic: Unpacking the Multidimensional Impact of Chronic Stress on Global Health on September 20, 2026 Posted by
The End of an Era: House Passes "Common Cents Act" to Permanently Retire the Penny on September 20, 2026 Posted by
Posted in Caregiver Support A New Era for Influenza: Moderna’s mRNA Vaccine Nears U.S. Approval on June 19, 2026
Posted in Digital Health Tools A Regulatory Reversal: UniQure’s Path to Approval for Huntington’s Gene Therapy Clears Key Hurdle on June 17, 2026
Posted in Medical Innovations The mRNA Flu Frontier: FDA Scrutiny Clouds Moderna’s Path to mFlusiva Approval on June 17, 2026
Posted in Mental Health Recovery The Efficacy Gap: Investigating the Controversial FDA Approval of Escitalopram for Pediatric Anxiety on June 15, 2026
Posted in Digital Health Tools The Regulatory Tightrope: FDA Rejects Proposal to Streamline AI Medical Device Approval on May 31, 2026 rifanmuazin
Posted in Digital Health Tools AbbVie Strengthens Oncology Portfolio with FDA Approval of Decnupaz for Rare Blood Cancer on May 29, 2026 rifanmuazin
Posted in Digital Health Tools A New Frontier in Cardiology: AstraZeneca’s Baxfendy Receives FDA Approval to Tackle Treatment-Resistant Hypertension on May 18, 2026 rifanmuazin
Posted in Medical Innovations A New Frontier in Cardiology: AstraZeneca’s Baxfendy Receives FDA Approval on May 18, 2026 rifanmuazin
